Abstract
We have used molecular dynamics simulations to investigate the effect of phosphorylation and mutation on the cytoplasmic domain of phospholamban (PLB), a 52-residue protein that regulates the calcium pump in cardiac muscle. Simulations were carried out in explicit water systems at 300 K for three peptides spanning the first 25 residues of PLB: wild-type (PLB(1-25)), PLB(1-25) phosphorylated at Ser16 and PLB(1-25) with the R9C mutation, which is known to cause human heart disease. The unphosphorylated peptide maintains a helical conformation from 3 to 15 throughout a 26-ns simulation, in agreement with spectroscopic data. Comparison with simulations of a fourth peptide truncated at Pro21 showed the importance of the region from 17 to 21 in preventing local unfolding of the helix. The results suggest that residues 11-16 are more likely to unfold when specific capping motifs are not present. It is proposed that protein kinase A exploits the intrinsic flexibility of the 11-21 region when binding PLB. In agreement with available CD and NMR data, the simulations show a decrease in the helical content upon phosphorylation. The phosphorylated peptide is characterized by helix spanning residues 3-11, followed by a turn that optimizes the salt-bridge interaction between the side chains of the phosphorylated Ser-16 and Arg-13. Replacing Arg-9 with Cys results in unfolding of the helix from C9 and an overall decrease of the helical conformation. The simulations show that initiation of unfolding is due to increased solvent accessibility of the backbone atoms near the smaller Cys. It is proposed that the loss of inhibitory potency upon Ser-16 phosphorylation or R9C mutation of PLB is due to a similar mechanism, in which the partial unfolding of the cytoplasmic helix of PLB results in a conformation that interacts with the cytoplasmic domain of the calcium pump to relieve its inhibition.
MeSH Terms
Algorithms
Amino Acid Motifs
Amino Acid Sequence
Animals
Arginine/chemistry
Calcium/chemistry,metabolism
Calcium-Binding Proteins/chemistry,genetics,metabolism
Calcium-Transporting ATPases/chemistry
Circular Dichroism
Computer Simulation
Cysteine/chemistry
Cytoplasm/metabolism
Magnetic Resonance Spectroscopy
Models, Molecular
Molecular Sequence Data
Mutation
Myocardium/metabolism
Peptides/chemistry
Phosphorylation
Proline/chemistry
Protein Conformation
Protein Denaturation
Protein Folding
Protein Structure, Secondary
Protein Structure, Tertiary
Sarcoplasmic Reticulum/metabolism
Serine/chemistry
Temperature
Chemicals
Calcium-Binding Proteins
Peptides
phospholamban
Serine
Arginine
Proline
Calcium-Transporting ATPases
Cysteine
Calcium
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Thomas David D
References (30)
30 references, click to expand
-
Statistical analysis of protein kinase specificity determinants.
FEBS Lett. 1998 Jun 23;430(1-2):45-50
PMID: 9678592
-
The Eleventh Datta Lecture. The structural basis for substrate recognition and control by protein kinases.
FEBS Lett. 1998 Jun 23;430(1-2):1-11
PMID: 9678585
-
Structure of the 1-36 amino-terminal fragment of human phospholamban by nuclear magnetic resonance and modeling of the phospholamban pentamer.
Biophys J. 1999 Apr;76(4):1784-95
PMID: 10096878
-
Mapping the interaction surface of a membrane protein: unveiling the conformational switch of phospholamban in calcium pump regulation.
Proc Natl Acad Sci U S A. 2005 Mar 29;102(13):4747-52
PMID: 15781867
-
Structural studies on phospholamban and implications for regulation of the Ca(2+)-ATPase.
Ann N Y Acad Sci. 1998 Sep 16;853:63-78
PMID: 10603937
-
Physical interactions between phospholamban and sarco(endo)plasmic reticulum Ca2+-ATPases are dissociated by elevated Ca2+, but not by phospholamban phosphorylation, vanadate, or thapsigargin, and are enhanced by ATP.
J Biol Chem. 2000 May 19;275(20):15034-8
PMID: 10809745
-
Physical reasons for the unusual alpha-helix stabilization afforded by charged or neutral polar residues in alanine-rich peptides.
Proc Natl Acad Sci U S A. 2000 Nov 21;97(24):13075-9
PMID: 11078529
-
Helix-coil transition of PrP106-126: molecular dynamic study.
Proteins. 2001 Dec 1;45(4):382-96
PMID: 11746686
-
Effect of phosphorylation on alpha-helix stability as a function of position.
Biochemistry. 2002 Feb 12;41(6):1897-905
PMID: 11827536
-
Alpha-helical stabilization by side chain shielding of backbone hydrogen bonds.
Proc Natl Acad Sci U S A. 2002 Mar 5;99(5):2782-7
PMID: 11867710
-
Structure of the 1-36 N-terminal fragment of human phospholamban phosphorylated at Ser-16 and Thr-17.
Biophys J. 2002 Jul;83(1):484-90
PMID: 12080135
-
Solid-state NMR and rigid body molecular dynamics to determine domain orientations of monomeric phospholamban.
J Am Chem Soc. 2002 Aug 14;124(32):9392-3
PMID: 12167032
-
Absolute comparison of simulated and experimental protein-folding dynamics.
Nature. 2002 Nov 7;420(6911):102-6
PMID: 12422224
-
Modeling of the inhibitory interaction of phospholamban with the Ca2+ ATPase.
Proc Natl Acad Sci U S A. 2003 Jan 21;100(2):467-72
PMID: 12525698
-
Helix propensities of short peptides: molecular dynamics versus bioinformatics.
Proteins. 2003 Mar 1;50(4):552-62
PMID: 12577261
-
Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban.
Science. 2003 Feb 28;299(5611):1410-3
PMID: 12610310
-
Structure and function of integral membrane protein domains resolved by peptide-amphiphiles: application to phospholamban.
Biopolymers. 2003 Jul;69(3):283-92
PMID: 12833255
-
Phospholamban: a crucial regulator of cardiac contractility.
Nat Rev Mol Cell Biol. 2003 Jul;4(7):566-77
PMID: 12838339
-
Phosphorylation by cAMP-dependent protein kinase modulates the structural coupling between the transmembrane and cytosolic domains of phospholamban.
Biochemistry. 2003 Sep 16;42(36):10674-82
PMID: 12962492
-
NMR solution structure and topological orientation of monomeric phospholamban in dodecylphosphocholine micelles.
Biophys J. 2003 Oct;85(4):2589-98
PMID: 14507721
-
Spatial and dynamic interactions between phospholamban and the canine cardiac Ca2+ pump revealed with use of heterobifunctional cross-linking agents.
J Biol Chem. 2003 Nov 28;278(48):48348-56
PMID: 12972413
-
Electron paramagnetic resonance reveals a large-scale conformational change in the cytoplasmic domain of phospholamban upon binding to the sarcoplasmic reticulum Ca-ATPase.
Biochemistry. 2004 May 18;43(19):5842-52
PMID: 15134458
-
(1)H/(15)N heteronuclear NMR spectroscopy shows four dynamic domains for phospholamban reconstituted in dodecylphosphocholine micelles.
Biophys J. 2004 Aug;87(2):1205-14
PMID: 15298923
-
Phospholamban structural dynamics in lipid bilayers probed by a spin label rigidly coupled to the peptide backbone.
Proc Natl Acad Sci U S A. 2004 Oct 5;101(40):14437-42
PMID: 15448204
-
Molecular dynamics simulations of helix denaturation.
J Mol Biol. 1992 Feb 20;223(4):1121-38
PMID: 1538392
-
Amino acids Glu2 to Ile18 in the cytoplasmic domain of phospholamban are essential for functional association with the Ca(2+)-ATPase of sarcoplasmic reticulum.
J Biol Chem. 1994 Jan 28;269(4):3088-94
PMID: 7905483
-
A revised set of potentials for beta-turn formation in proteins.
Protein Sci. 1994 Dec;3(12):2207-16
PMID: 7756980
-
Solution structure of the cytoplasmic domain of phopholamban: phosphorylation leads to a local perturbation in secondary structure.
Biochemistry. 1995 Jun 13;34(23):7603-13
PMID: 7779806
-
Helix capping.
Protein Sci. 1998 Jan;7(1):21-38
PMID: 9514257
-
Phosphorylation stabilizes the N-termini of alpha-helices.
Biopolymers. 1999 Mar;49(3):225-33
PMID: 9990840